242588 ⎘
Non-hormonal steroid modulators of NF-kB for treatment of disease
#2Compositions and methods for the systemic treatment of arthritis
#3Non-hormonal steroid modulators of NF-kB for treatment of disease
#4THERAPEUTIC AGENT FOR CHRONIC ARTHRITIDES DISEASES OF CHILDHOOD-RELATED DISEASES
#5Non-hormonal steroid modulators of NF-kB for treatment of disease
#6Compositions and methods for the systemic treatment of arthritis
#7Anti-TNF antibodies, compositions, methods and uses
#8Compositions and methods for the systemic treatment of arthritis
#9Methods of modulating immunity
#10Anti-TNF antibodies, compositions, methods and uses
#11Non-hormonal steroid modulators of NF-κB for treatment of disease
#12Utilization of dialkylfumarates
#13Anti-TNF antibodies, compositions, methods and uses
#14Method for treating osteoarthritis
#15Indene derivatives as pharmaceutical agents
#16COMPOSITIONS AND METHODS FOR THE SYSTEMIC TREATMENT OF ARTHRITIS
#17Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#18FGF homologs compositions and uses thereof
#19Compositions and Methods for the Systemic Treatment of Arthritis
#20Aminopterin Dosage Forms and Methods for Inflammatory Disorders
#21Non-hormonal steroid modulators of NF-κB for treatment of disease
#22Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases
#23Utilization of dialkylfumarates
#24BORRELLIA BURGDORFERI BACTERIN
#25Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disorders
#26Method for treating a mammal by administration of a compound having the ability to release CO
#27Therapeutic agent for chronic arthritides diseases of childhood-related diseases
#28INDENE DERIVATIVES AS PHARMACEUTICAL AGENTS
#29Methods of Modulating Immunity
#30Methods for treating osteoarthritis
#31Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling
#32Indene derivatives as pharmaceutical agents
#332-Alkylidene-18,19-Dinor-Vitamin D Compounds
#34COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#35FGF homologs compositions and uses thereof
#36Indene derivatives as pharmaceutical agents
#37Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#38Non-hormonal steroid modulators of NF-κB for treatment of disease
#39Methods and compositions of inhibiting complement and cellular activation with Dextran Sulfate
#40Compositions and methods for the systemic treatment of arthritis
#41Compositions and methods for the systemic treatment of arthritis
#42Use of creatine analogues and creatine kinase modulators for the prevention and treatment of obesity and its related disorders
#43Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases
#44Anti-TNF antibodies, compositions, methods and uses
#45Esterified fatty acid composition
#46ETHYLENE GLYCOL ESTERS AS PHOTOACTIVE AGENTS
#47Method of inhibiting the emigration of cells from the intravascular compartment into tissues
#48Composition and method for treating and preventing musculoskeletal and connective tissue disorders
#49Utilization of dialkylfumarates
#50Utilization of dialkylfumarates
#51Novel 4-Dedimethylaminotetracycline derivatives
#52Anti-TNF antibodies, compositions, methods and uses
#53Anti-TNF antibodies, compositions, methods and uses
#54COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#55Peptides that antagonize FPR class receptor mediated signaling
#56Nitrate esters of corticoid compounds and pharmaceutical applications thereof
#57Compounds and Methods for the Inhibition of the Expression of VCAM-1
#58Methods for treating inflammation
#59Compositions and Methods for the Systemic Treatment of Arthritis
#60Compositions and Methods for the Systemic Treatment of Arthritis
#61Compositions and methods for the systemic treatment of arthritis
#62Therapeutically active triazoles and their use
#63SUBSTITUTED ESTRATRIENES AS SELECTIVELY ACTIVE ESTROGENS
#64Medicaments containing panthenol
#65Aminopterin dosage forms and methods for inflammatory disorders
#66AMINOPTERIN DOSAGE FORMS
#67BORRELIA BURGDORFERI BACTERIN
#68Antagonists of interleukin-15
#69N2, N4-bis-aryl-5-fluoro-2,4-pyrimidinediamines
#70Solid dosage form containing a taste masked active agent
#71Utilization of dialkylfumarates
#72Utilization of dialkylfumarates
#73Method of Treating Cancer Using Dithiocarbamate Derivatives
#74Therapeutic uses of glandular kallikrein
#75Nutrient compositions for the treatment and prevention of inflammation and disorders associated therewith
#76Ethylene glycol esters as photoactive agents
#77Nitrate esters of corticoid compounds and pharmaceutical applications thereof
#78Therapeutic agent for chronic arthritides diseases of childhood-related diseases
#79Method for producing polyol-IFN-β conjugate
#80Methods of increasing cartilage deposition using FGF homologs
#81Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#82Combination of a lanthanum compound and bone enhancing agent for the treatment of bone diseases
#83Methods and composition for inhibition of angiogenesis
#84Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases
#85T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof
#86Method for treating osteoarthritis
#87Nitrate esters of corticoid compounds and pharmaceutical applications thereof
#88Method for treating a mammal by administration of a compound having the ability to release CO
#896,7-Oxygenated steroids and uses related thereto
#90Aminopterin dosage forms and methods for inflammatory disorders
#91Treatment of mucosal membranes
#92Estrogenic compounds as anti-mitotic agents
#93Nitrate esters of corticoid compounds and pharmaceutical applications thereof
#94Nitrate esters of corticoid compounds and pharmaceutical applications thereof
#95Nitrate esters of corticoid compounds and pharmaceutical applications thereof
#96Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
#97Therapeutic treatments using the direct application of antimicrobial metal compositions
#98Anti-angiogenic compositions and methods of use
#99Anti-angiogenic compositions and methods of use
#100Anti-angiogenic compositions and methods of use
#101Anti-angiogenic compositions and methods of use
#102Anti-angiogenic compositions and methods of use
#103Immunodulatory compositions and methods of use thereof
#104Treatment of inflammatory skin conditions
#105Novel T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof
#106Nucleic acids encoding antagonists of interleukin-15
#107Modified antibody variable domains
#1082-alkylidene-18,19-dinor-vitamin D compounds
#109Methods for the treatment of inflammatory joint disease
#110T-cell membrane protein (TIRC7) and peptides derived therefrom
#111Methods for inhibiting undesired angiogenesis in patients having tumors with thalidomide
#112Esterified fatty acid composition
#113Methods of modulating immunity
#114Compositions and methods for the systemic treatment of arthritis
#1154-dedimethylaminotetracycline derivatives
#116Method for administering selenium for treating patients suffering from systemic inflammatory response syndrome (SIRS), and composition for implementing the treatment
#117Method of inhibiting the emigration of cells from the intravascular compartment into tissues
#118N-(4 substituted phenyl)-anthranilic acid hydroxamate esters
#119Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases
#120Anti-inflammatory activity of a specific turmeric extract
#121Compounds and methods for the inhibition of the expression of VCAM-1
#122Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases
#123Novel FGF homologs
#124Solubility and Absorption Promoter
#125Anti-angiogenic compositions and methods of use
#126Borrelia burgdorferi bacterin
#127Methods for inhibiting lymphotoxin β receptor signalling
#128Ethylene glycol esters as photoactive agents
#129Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1H-[1,2,4]-triazole for the treatment of autoimmune diseases
#130Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
#131Compositions and methods directed towards sore muscles and joints
#132Nitrate esters of corticoid compounds and pharmaceutical applications thereof
#133Indene derivatives as pharmaceutical agents